Walvax BioTech (300142) — Financial Flexibility Index
Walvax BioTech (300142) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥182.25 Million (operating CF CN¥-33.52 Million minus capex CN¥215.77 Million) represents 0% of total liabilities (CN¥2.31 Billion). Also explore net asset growth rate of Walvax BioTech to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Walvax BioTech Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Walvax BioTech across 19 annual periods. Check Walvax BioTech PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Walvax BioTech (2007–2025)
Year-by-year free cash flow to debt coverage for Walvax BioTech. For the full company profile including market capitalisation, see 300142 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | CN¥1.00 Billion | CN¥494.37 Million | CN¥2.26 Billion | ▼ -9.8% |
| 2024 | 0.49x | CN¥1.59 Billion | CN¥1.04 Billion | CN¥3.22 Billion | ▼ -0.5% |
| 2023 | 0.50x | CN¥2.08 Billion | CN¥1.13 Billion | CN¥4.19 Billion | ▼ -6.0% |
| 2022 | 0.53x | CN¥2.29 Billion | CN¥1.20 Billion | CN¥4.35 Billion | ▲ +7.2% |
| 2021 | 0.49x | CN¥1.81 Billion | CN¥705.28 Million | CN¥3.68 Billion | ▲ +69.9% |
| 2020 | 0.29x | CN¥521.32 Million | CN¥114.19 Million | CN¥1.80 Billion | ▼ -5.4% |
| 2019 | 0.31x | CN¥413.84 Million | CN¥62.02 Million | CN¥1.35 Billion | ▲ +274.5% |
| 2018 | 0.08x | CN¥162.09 Million | CN¥-65.23 Million | CN¥1.98 Billion | ▼ -40.9% |
| 2017 | 0.14x | CN¥320.93 Million | CN¥-10.13 Million | CN¥2.32 Billion | ▲ +141.8% |
| 2016 | 0.06x | CN¥160.30 Million | CN¥-89.94 Million | CN¥2.80 Billion | ▼ -5.2% |
| 2015 | 0.06x | CN¥195.34 Million | CN¥-69.41 Million | CN¥3.23 Billion | ▼ -4.6% |
| 2014 | 0.06x | CN¥174.46 Million | CN¥-65.93 Million | CN¥2.76 Billion | ▼ -24.5% |
| 2013 | 0.08x | CN¥267.94 Million | CN¥-121.73 Million | CN¥3.20 Billion | ▼ -75.3% |
| 2012 | 0.34x | CN¥434.25 Million | CN¥78.38 Million | CN¥1.28 Billion | ▼ -65.6% |
| 2011 | 0.99x | CN¥289.54 Million | CN¥91.98 Million | CN¥293.62 Million | ▲ +70.7% |
| 2010 | 0.58x | CN¥251.53 Million | CN¥86.71 Million | CN¥435.52 Million | ▼ -22.2% |
| 2009 | 0.74x | CN¥156.94 Million | CN¥82.18 Million | CN¥211.43 Million | ▲ +537.6% |
| 2008 | 0.12x | CN¥23.70 Million | CN¥-5.69 Million | CN¥203.54 Million | ▼ -53.6% |
| 2007 | 0.25x | CN¥50.10 Million | CN¥31.85 Million | CN¥199.86 Million | — |